Fundraising Fox
Vinith Johnson

Vinith Johnson

YC W22

Founder at Sophys

Vinith Johnson conducted cognitive neuroscience research at Neuroscape developing digital therapeutics for ADHD and contributed to the development of a game-based FDA-approved therapeutic product. He subsequently served as tech lead for a clinical trial using adaptive deep brain stimulation for cervical dystonia, and later worked at San Francisco General Hospital collaborating with surgeons on neurosurgical and pediatric surgical device development.

Intro paths

YC

Vinith went through Y Combinator (Winter 2022) β€” any YC alum in your network can reach them through the YC community.

β†’

In turn, Vinith can intro founders to Sophys's investors below.

Sophys's investors Β· 1